Send Press Releases | Advertise with Us

Novartis hires veteran Wall Street analyst Ronny Gal as chief M&A strategist

Published

Related posts:

  1. Generic manufacturers in developing countries licensed to make Merck’s COVID-19 pill
  2. New artificial intelligence model shows more accuracy in diagnosing pediatric ear infections
  3. GSK’s Jemperli gets NICE approval for use in women with aggressive endometrial cancer
  4. Chronic disease management startup PhableCare raises US$24.5 million in Series B funding
  5. Bicycle Health raises US$50M for virtual opioid use disorder treatment

Newer Post

Thumbnail for Novartis hires veteran Wall Street analyst Ronny Gal as chief M&A strategist

UnitedHealth to sell Change Healthcare’s claims business for US$2.2 billion

Older Post

Thumbnail for Novartis hires veteran Wall Street analyst Ronny Gal as chief M&A strategist

Pfizer recalls blood pressure meds due to carcinogen contaminants

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.